Renaissance Capital logo

OKUR News

US IPO Weekly Recap: The IPO market cools off in a 2 IPO week

VECT

Just two IPOs priced this past week, raising $222 million as the US IPO market continued to cool down. They were joined by eight SPACs that raised $1.5 million. The IPO pipeline remained active, with 13 IPOs and 14 SPACs submitting initial filings this week. ...read more

Rare disease biotech Reneo Pharmaceuticals prices IPO at $15, the low end of the range

OnKure Therapeutics (Reneo Pharmaceuticals) logo

Reneo Pharmaceuticals, a Phase 2 biotech developing therapies for rare genetic mitochondrial diseases, raised $94 million by offering 6.3 million shares at $15, the low end of the range of $15 to $17. At pricing, Reneo  commands a fully diluted market cap...read more

Rare disease biotech Reneo Pharmaceuticals sets terms for $100 million IPO

OnKure Therapeutics (Reneo Pharmaceuticals) logo

Reneo Pharmaceuticals, a Phase 2 biotech developing therapies for rare genetic mitochondrial diseases, announced terms for its IPO on Monday. The San Diego, CA-based company plans to raise $100 million by offering 6.3 million shares at a price range of $15...read more

US IPO Weekly Recap: The IPO market heats up in an 11 IPO week

TUYA

The IPO market stayed busy this past week, with 11 IPOs raising $3.0 billion. The week’s IPOs were joined by 24 SPACs that raised $8.4 billion. New filers continued to fill the IPO pipeline, with 8 IPOs and 46 SPACs submitting initial filings. ...read more